Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Change in Receivables (2020 - 2025)

Historic Change in Receivables for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to $4.4 million.

  • PROCEPT BioRobotics' Change in Receivables fell 5890.24% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.0 million, marking a year-over-year decrease of 4851.21%. This contributed to the annual value of $36.0 million for FY2024, which is 863.06% up from last year.
  • As of Q3 2025, PROCEPT BioRobotics' Change in Receivables stood at $4.4 million, which was down 5890.24% from $2.7 million recorded in Q2 2025.
  • Over the past 5 years, PROCEPT BioRobotics' Change in Receivables peaked at $14.8 million during Q4 2024, and registered a low of -$3.9 million during Q1 2025.
  • Over the past 5 years, PROCEPT BioRobotics' median Change in Receivables value was $2.7 million (recorded in 2025), while the average stood at $4.5 million.
  • Per our database at Business Quant, PROCEPT BioRobotics' Change in Receivables crashed by 76697.25% in 2021 and then skyrocketed by 63114.64% in 2024.
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Change in Receivables stood at -$1.9 million in 2021, then surged by 228.78% to $2.4 million in 2022, then skyrocketed by 465.08% to $13.8 million in 2023, then grew by 7.84% to $14.8 million in 2024, then plummeted by 70.66% to $4.4 million in 2025.
  • Its last three reported values are $4.4 million in Q3 2025, $2.7 million for Q2 2025, and -$3.9 million during Q1 2025.